Hengbing Wang

Safety and Efficacy Evaluation of 4SCAR19 Chimeric Antigen Receptor-Modified T Cells Targeting B Cell Acute Lymphoblastic Leukemia - Three-Year Follow-up of a Multicenter Phase I/II Study

Lung-Ji Chang, Shih-Ting Tsao, Huyong Zheng, 2016 .

Phase II study of panobinostat and bortezomib in patients with pancreatic cancer progressing on gemcitabine-based therapy.

A. Dudek, Q. Cao, Hengbing Wang, 2012, Anticancer research.

Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer

R. Kratzke, S. Russell, M. Federspiel, 2015, Oncotarget.

Chimeric Antigen Receptor 4SCAR19-Modified T Cells in Acute Lymphoid Leukemia: a Phase II Multi-Center Clinical Trial in China

He Huang, Yu-Hong Chen, Lung-Ji Chang, 2015 .

Impact of prophylactic/preemptive donor lymphocyte infusion and intensified conditioning for relapsed/refractory leukemia: a real-world study

F. Gao, Shunqing Wang, Yu Wang, 2020, Science China Life Sciences.

Impact of prophylactic/preemptive donor lymphocyte infusion and intensified conditioning for relapsed/refractory leukemia: a real-world study

F. Gao, Shunqing Wang, Yu Wang, 2020, Science China Life Sciences.

Measles Vaccine Strains for Virotherapy of Non–Small-Cell Lung Carcinoma

R. Kratzke, S. Russell, M. Federspiel, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.